Ra Pharmaceuticals (RARX) Secures Development Milestone Payment Under Agreement with Merck (MRK)
Tweet Send to a Friend
Ra Pharmaceuticals, Inc. (NASDAQ: RARX) today announced that it has received a development milestone payment under its collaboration agreement with ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE